News & Updates

Higher MCFAs tied to lower diabetes risk
Higher MCFAs tied to lower diabetes risk
04 Feb 2025 byStephen Padilla

Dietary medium-chain fatty acids (MCFAs) are inversely associated with the risk of developing type 2 diabetes mellitus (T2DM), reports a study, noting a possible interaction between genetic susceptibility and circulating octanoic acid in moderating diabetes risk.

Higher MCFAs tied to lower diabetes risk
04 Feb 2025
Dupilumab trumps MTX, cyclosporine in paediatric AD
Dupilumab trumps MTX, cyclosporine in paediatric AD
03 Feb 2025 byStephen Padilla

The use of dupilumab in children with moderate-to-severe atopic dermatitis (AD) results in greater improvements in AD severity, better adherence, and fewer treatment-emergent adverse events (TEAEs) than methotrexate (MTX) or cyclosporine, as shown by 2-year interim results from the PEDISTAD study.

Dupilumab trumps MTX, cyclosporine in paediatric AD
03 Feb 2025